Should clinicians start measuring flow mediated dilation response in patients with systemic lupus erythematosus?

Journal of Rheumatology

Volumn 38, Issue 7, 2011, Pages 1231-1233

  Lau, Chak Sing ^a   Cheung, Tommy ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR INHIBITOR; PROSTACYCLIN; VON WILLEBRAND FACTOR;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CORONARY ARTERY CALCIFICATION; DISEASE EXACERBATION; DOPPLER ECHOGRAPHY; EDITORIAL; ENDOTHELIUM; ENZYME RELEASE; FLOW MEDIATED DILATION; HEART INFARCTION; HUMAN; LONG TERM CARE; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT MONITORING; PRIORITY JOURNAL; PULSE WAVE; SHEAR STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASODILATATION;

BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; REGIONAL BLOOD FLOW; VASODILATION;

EID: 79959976107     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110635     Document Type: Editorial

References (20)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
2. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15. (Pubitemid 27084212)
3. Nikpour M, Urowitz MB, Gladman DA. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin N Am 2005;31:329-58.
4. Petri M. Clinical research in systemic lupus erythematosus: immediate relevance to clinic practice. Int J Rheum Dis 2011;14:1-5.
5. Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintani A, Raggi P, et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 2007;66:208-14. (Pubitemid 46226056)
6. Sabio J, Zamora-Pasadas M, Jiménez-Jáimez J, Albadalejo F, Vargas-Hitos J, Rodríguez del Aguila MD, et al. Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus 2008;17:849-59.
7. Szekanecz Z, Koch AE. Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther 2008;10:224.
8. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406. (Pubitemid 37542988)
9. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407-15. (Pubitemid 37542989)
10. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22. (Pubitemid 29024679)
11. Yan RT, Bluemke D, Gomes A, Burke G, Shea S, Liu K, et al. Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2011;57:1735-44.
12. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography); Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49:378-402.
13. Gonzalez MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003;115 Suppl 8A:99(S)-106(S).
14. Devaraj S, Yun JM, Adamson G, Galvez J, Jialal I. C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res 2009;84:479-84.
15. Le Brocq M, Leslie SJ, Milliken P, Megson IL. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal 2008;10:1631-74.
16. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74. (Pubitemid 24344241)
17. Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002;29:292-7. (Pubitemid 34118776)
18. Johnson SR, Harvey PJ, Floras JS, Iwanochko M, Ibanez D, Gladman DD, et al. Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations. Lupus 2004;13:590-3. (Pubitemid 39145488)
19. Mak A, Liu Y, Ho RC-M. Endothelium-dependent but not endothelium- independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression. J Rheumatol 2011;38:1296-303.
20. Bots ML, Westerink J, Rabelink TJ, de Koning EJ. Assessment of flow-mediated vasodilation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 2005;26:363-8. (Pubitemid 40283095)